The Effect of Celecoxib on Neuroinflammation in MDD

Clinical trial NCT04814355 · COMPLETED

Trial details

NCT number: NCT04814355
Sponsor: Stony Brook University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Major Depressive Disorder Neuroinflammation

Start date: 2018-08-01
Primary completion: 2025-08-11
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.